STEFAN HARTMANN: Open Payments
NPI 1861966020 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$746 in 8 payments from 5 companies in 2025. Trend: 2023 $521 · 2024 $335 · 2025 $746
Food & beverage: $746
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 3 | $245 |
| Novo Nordisk Inc | 2 | $226 |
| Madrigal Pharmaceuticals | 1 | $148 |
| GENZYME CORPORATION | 1 | $77 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $51 |
Products named: REZDIFFRA, Ozempic, Wegovy, Kerendia.
Industry payments across FL — which companies pay providers there.
